Representative Publications In past years(# co-first author, * Corresponding author):

[1] Xu L#, Zheng Q#, Zhu R#, Yin Z#, Yu H#, Lin Y, Wu Y, He M, Huang Y, Jiang Y, Sun H, Zha Z, Yang H, Huang Q, Zhang D, Chen Z, Ye X, Han J, Yang L, Liu C, Que Y, Fang M, Gu Y, Zhang J, Luo W, Zhou ZH*, Li S*, Cheng T*, Xia N*. Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating. Cell Host Microbe. 2021, 29(3):448-462.e5.

[2] Xu L #, Zheng Q #, Li S#, He M, Wu Y, Li Y, Zhu R, Yu H, Hong Q, Jiang J, Li Z, Li S, Zhao H, Yang L, How W, Wang W, Ye X, Zhang J, Baker T, Cheng T*, Zhou H*, Yan X*, Xia N*. Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody [J]. Nature Communications, 2017, 8(1): 505.（F1000推荐论文）

[3] He M#, Xu L#, Zheng Q#, Zhu R#, Yin Z#, Zha Z, Lin Y, Yang L, Huang Y, Ye X, Li S, Hou W, Wu Y, Han J, Liu D, Li Z, Chen Z, Yu H, Que Y, Wang Y, Yan X, Zhang J, Gu Y, Zhou ZH*, Cheng T*, Li S*, Xia N*. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16. Cell Host Microbe. 2020, 27(2):249-261.（获评交叉科学领域“细胞出版社2020中国年度论文”）

[4] Zheng Q#, Zhu R#, Yin Z#, Xu L#, Sun H#, Yu H#, Wu Y, Jiang Y, Huang Q, Huang Y, Zhang D, Liu L, Yang H, He M, Zhou Z, Jiang Y, Chen Z, Zhao H, Que Y, Kong Z, Zhou L, Li T, Zhang J, Luo W, Gu Y*, Cheng T*, Li S*, Xia N*. Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail. Cell Host Microbe. 2022, 1279-1294 e1276. 10.1016/j.chom.

[5] Zhu R#,Xu L#, Zheng Q#, Cui Y#, Li S#, He M, Yin Z, Liu D, Li S, Li Z, Chen Z, Yu H, Que Y, Liu C, Kong Z, Zhang J, Baker TS, Yan X*, Hong Zhou Z*, Cheng T*, Xia N*. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10. Science Advances. 2018, 4(9):eaat7459.

[6] Zheng Q#, Zhu R#, Xu L#, He M#, Yan X, Liu D, Yin Z, Wu Y, Li Y, Yang L, Hou W, Li S, Li Z, Chen Z, Li Z, Yu H, Gu Y, Zhang J, Baker TS, Zhou ZH, Graham BS*, Cheng T*, Li S*, Xia N*. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Nature Microbiology. 2019, 4(1): 124-133.

[7] Xu L#, He D#, Li Z, Zheng J, Yan L, Yu M, Yu H, Chen Y, Que Y, Shih J.W, Liu G, Zhang J, Zhao Q, Cheng T*, Xia N*. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop[J]. Theranostics, 2014, 4(5): 498-513.

[8] Liu D#, Xu L#, Zhu R, Yin Z, Lin Y, Hou W, Li S, He S, Cheng T*, Xia N. Development of an efficient neutralization assay for Coxsackievirus A10. Applied Microbiology and Biotechnology. 2019, 103(4):1931-1938

[9] Zhou B#, Xu L#, Zhu R, Tang J, Wu Y, Su R, Yin Z, Liu D, Jiang Y, Wen C, You M, Dai L, Lin Y, Chen Y, Yang H, An Z, Fan C*, Cheng T*, Luo W*, Xia N. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential. Antiviral Research. 2019, 161:28-35.

[10] Wang Z#, Xu L#, Yu H#, Lv P#, Lei Z, Zeng Y, Liu G*, Cheng T*, Ferritin nanocage-based antigen delivery nanoplatforms: epitope engineering for peptide vaccine design. Biomater Sci,. 2019 Apr 23;7(5):1794-1800.